First Tracks Biotherapeutics Inc (TRAX) Stock Research

Today

First Tracks price target raised to $57 from $44 at H.C. Wainwright

TRAX

6:05 AM

First Tracks Biotherapeutics price target raised by $17 at Barclays, here's why

TRAX

5:21 AM

Yesterday

First Tracks Biotherapeutics reports Q2 EPS (95c), consensus (80c)

TRAX

Yesterday, 4:55 PM

Monday

First Tracks Biotherapeutics management to meet with Piper Sandler

TRAX

Aug 10, 3:50 PM

First Tracks Biotherapeutics price target raised by $20 at UBS

TRAX

Aug 10, 9:17 AM

Over a week ago

First Tracks Biotherapeutics price target raised by $30 at Wedbush, here's why

Jul 28, 7:56 AM

First Tracks Biotherapeutics price target raised by $25 at Wells Fargo, here's why

Jul 28, 6:13 AM

After Forte acquisition, H.C. Wainwright says First Tracks could be target

Jul 27, 12:01 PM

First Tracks Biotherapeutics price target raised by $8 at Barclays, here's why

TRAX

Jul 21, 6:18 AM

First Tracks Biotherapeutics price target raised by $14 at H.C. Wainwright, here's why

Jul 10, 6:04 AM

First Tracks Biotherapeutics initiated with bullish view at Wells Fargo, here's why

TRAX

Jun 8, 4:58 AM

Two new option listings and one option delisting on May 11th

May 11, 8:30 AM

First Tracks Biotherapeutics files to sell 10.5M shares of common for holders

TRAX

May 8, 4:38 PM

AnaptysBio price target lowered by $2 at Piper Sandler, here's why

May 4, 7:45 AM

First Tracks Biotherapeutics initiated with bullish view at Piper Sandler, here's why

TRAX

May 4, 4:36 AM

First Tracks Biotherapeutics initiated with bullish view at H.C. Wainwright, here's why

TRAX

Apr 28, 6:09 AM

First Tracks Biotherapeutics initiated with bullish view at Leerink, here's why

Apr 24, 7:31 AM

First Tracks Biotherapeutics initiated with bullish view at JPMorgan, here's why

TRAX

Apr 23, 5:00 AM

First Tracks Biotherapeutics initiated with bullish view at Barclays, here's why

TRAX

Apr 22, 5:07 AM

AnaptysBio price target lowered to $60 from $90 at UBS

Apr 21, 8:28 AM

First Tracks Biotherapeutics initiated with bullish view at UBS, here's why

TRAX

Apr 21, 5:01 AM

First Tracks Biotherapeutics debuts on Nasdaq

TRAX

Apr 20, 9:36 AM

AnaptysBio price target raised by $29 at Stifel, here's why

Mar 5, 6:43 AM

No more stories